AzTrials
AzTrials

Eating BehaviourGREFFENCT02859506

Eating Behaviour and Gustatory Sensitivity Before and After Liver Transplant in Cirrhotic Patients

A study testing Respiratory quotient and Olfactory liking in people with Eating Behaviour and Liver Transplant, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Today, we know that olfactogustatory alterations occur in cirrhotic patients before the liver transplant but no study has been conducted to show eventual disturbances after the transplantation able to explain modifications in eating behaviour. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Eating Behaviour, Liver Transplant
What is being tested?
Respiratory quotient and Olfactory liking
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
73 participants
Where
1 siteFrance
Study dates
3 Jul 2015to 13 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • persons who have provided written informed consent
  • persons aged between 18 and 70 years
  • persons waiting for a liver transplantation (group LT)
  • persons with stable liver damage
  • persons waiting for a kidney transplantation (KT)
  • healthy subjects (control group) no known disease

Who cannot join

  • persons without national health insurance cover
  • persons with chronic infection,
  • persons with acute infection,
  • persons with progressive cancer,
  • persons with an antibiotic treatment,
  • persons who drink alcohol,
Show all 10Show fewer
  • pregnant or breast-feeding women,
  • persons with an aversion to the foods proposed in the study,
  • persons taking treatments known to interfere with gustatory and olfactory performance,
  • adults under guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier Universitaire

    Dijon, 21079

Other trials in France

About this study

Today, we know that olfactogustatory alterations occur in cirrhotic patients before the liver transplant but no study has been conducted to show eventual disturbances after the transplantation able to explain modifications in eating behaviour. In parallel, the metabolic status, itself dependent on liver metabolism, influences food preferences and is modified after the transplantation as the liver recovers its ability to store glycogen, but is not able to inform the brain as the afferent nerve impulses have been suppressed. The innovative aspect of this project is to provide information on the importance of the liver in the regulation of energy homeostasis.

The results of this study will improve our understanding of eating behaviour and olfactogustatory sensitivity and allow us to orient liver transplant patients towards appropriate diets.

Being tested
Respiratory quotient, Olfactory liking
Medical subject headings
Feeding Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Respiratory quotientOther

  • Olfactory likingOther

Study groups in NCT02859506
Study groupRoleWhat they receive
liver transplantExperimentalNot described
Receives: Other: Respiratory quotient; Other: Olfactory liking
kidney transplantActive comparatorNot described
Receives: Other: Respiratory quotient; Other: Olfactory liking
controlPlacebo comparatorNot described
Receives: Other: Respiratory quotient; Other: Olfactory liking
stable liver damageActive comparatorNot described
Receives: Other: Respiratory quotient; Other: Olfactory liking

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in respiratory quotient (RQ) by indirect calorimetry compared with baseline values

    Measured: At month 0, month 3, month 9 and month 15

  2. Change in olfactory liking compared with baseline values by questionnaire

    Measured: At month 0, month 3, month 9 and month 15

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2016 (estimated)
  2. Study start3 Jul 2015
  3. Primary completion13 Dec 2019
  4. Study completion13 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02859506
Sponsor's protocol ID
BRONDEL INRA 2013
Acronym
GREFFE
Status last verified
Feb 2024
First submitted
4 Aug 2016
Last updated
22 Feb 2024
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Respiratory quotient and Olfactory liking in people with Eating Behaviour and Liver Transplant, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in respiratory quotient (RQ) by indirect calorimetry compared with baseline values (time frame: At month 0, month 3, month 9 and month 15). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in